Skip to main content
DMAC logo

DMAC · DiaMedica Therapeutics Inc. · Debt

Track DMAC — free
$9.33 -0.33 (-3.42%) At close · Nov 12 Earnings today Play latest call Q2 2026 earnings call transcript
Market Cap
$503.13M
Shares
53.93M
Volume · Nov 12 187.78K Avg daily vol (3M) 194.88K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current finance lease liabilities 2026-09-30 USD 7,000 10-Q filed 2026-11-12
Noncurrent finance lease liabilities 2026-09-30 USD 0 10-Q filed 2026-11-12
Operating lease liabilities 2026-09-30 USD 150,000 10-Q filed 2026-11-12
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 110,000
Noncurrent operating lease liabilities
USD 40,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1401040 CUSIP 25253X207 13F (30d) 47 filings 46 filers Visit website Investor relations